New cancer strategy gets £750 million boost
January 13, 2011Cancer, NHS, cancer funding, cancer strategy
The government has published a new ‘Strategy for Cancer’ that seeks to increase preventive measures and improve outcomes for oncology …
Digital Pharma: Pfizer launches Dutch prescription service
January 12, 2011Medical Communications Digital Pharma blog, Holland, Pfizer, consumer healthcare, disease awareness campaigns, healthcare coaching, ilivi.nl, patient information
Pfizer has tied up with an online pharmacy to break new ground in patient services in Holland with ilivi.nl. The …
Amgen aims for oncology expansion and a wider denosumab license
January 12, 2011Research and Development AMG- 479, AMG-386, Amgen, Cancer, Pancreatic cancer, denosumab, motasenib
Amgen is seeking to increase the use of its bone drug denosumab and further its reach into the oncology market, …
Call to share public health research more openly
January 12, 2011Research and Development Bill and Melinda Gates Foundation, Wellcome Trust, data sharing, public health
The only way that pressing needs in global public health can be met is for research to be shared more …
Lilly and Boehringer sign major diabetes collaboration
January 12, 2011Research and Development BI10773, Boehringer Ingelheim, Eli Lilly, LY2605541, LY2963016, TGF-beta monoclonal antibody, diabetes, lilly, linagliptin, type II diabetes
Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …
Dr Simon Thorn joins Spectrum Regulatory Solutions
January 12, 2011Research and Development Dr Simon Thorn, Specrum Regulatory Services, appointment, research and development
Spectrum Regulatory Solutions has appointed Dr Simon Thorn as a senior regulatory writer. He has more than 15 years experience …
Marketing authorisations for medicines: UK Decentralised Procedure slots available in all therapeutic areas in 2011
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The MHRA has reported it has RMS decentralised procedure slots available in 2011 for all therapeutic areas, including biologicals and …
Servier’s Mediator provokes French drug safety controversy
January 12, 2011Sales and Marketing AFSSAPS, France, Mediator, Servier, benfluorex, drug safety
Serious questions are being asked about drug safety monitoring in France in connection with Servier’s Mediator (benfluorex) which was withdrawn …
Regulatory assistance available to Small and Medium-sized Enterprises (SMEs)
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The increasing number of SMEs in Europe is seen to be a driving force to facilitate economic growth, new product …
Deadline approaching for cancelling UK Licences
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The MHRA has recently advised all holders of UK marketing authorisations, registrations and licences to inform them by the 31st …
Updated report on origins of clinical trial participants
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The European Medicines Agency has published an updated report detailing the geographical origins of patients included in clinical trials for …
Scientific Advice and Guidance Available
January 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
In April, we reported how a joint pilot scheme operated by the UK Medicines & Healthcare Products Regulatory Agency (MHRA), …
UK trade associations form new life sciences lobbying group
January 11, 2011Research and Development, Sales and Marketing ABHI, ABPI, BIA, BIVDA, LifeSciencesUK, lobbying
Four industry trade associations including pharma body the ABPI have banded together to form a new lobbying group representing life …
Savient plays down gout drug manufacturing problems
January 11, 2011Manufacturing and Production, Sales and Marketing Krystexxa, Savient, biologic manufacturing, gout, manufacturing compliance, pegloticase
Savient Pharmaceuticals has reported that some production batches of Krystexxa, its recently-approved second-line treatment for gout, have failed to meet …
Novartis challenges Roche with MabThera biosimilar
January 11, 2011Research and Development Lonza MabThera, Novartis, Roche, Teva, biosimilar, rituximab
Novartis’ generics unit Sandoz has begun mid-stage trials of a biosimilar version of Roche’s blockbuster drug MabThera. The phase II …
FDA launches online transparency initiative
January 11, 2011Medical Communications, Research and Development, Sales and Marketing FDA, Joshua Sharfstein, transparency
The FDA has launched a new online resource to increase the transparency of its processes and help save companies time …
Dendreon will outsource first Provenge production in EU
January 11, 2011Manufacturing and Production Dendreon, Provenge, cancer vaccine, contract manufacturing, sipuleucel-T, vaccine manufacturing, vaccines
US oncology specialist Dendreon has decided to hire a contract manufacturer for its cell-based cancer therapy Provenge in Europe to …
Sanofi boosts emerging markets leadership team
January 11, 2011Sales and Marketing Brazil, China, Heraldo Marchezini, Japan, Jeremy Moulding Russia, Patrick Aghanian, Sanofi-Aventis, Thomas Kelly, appointments, emerging markets, sales and marketing
Sanofi-Aventis has bolstered its emerging markets team with the appointment of four senior managers. They are Patrick Aghanian, Thomas Kelly, …
Doctors use GSK’s Pandemrix as seasonal flu vaccines fall short
January 10, 2011Sales and Marketing GSK, GlaxoSmithKline, Pandemrix, flu, h1n1, influenza, vaccines
Doctors may have to use last year’s stock of the H1N1 vaccine Pandemrix as the government admits there are some …
Sanofi’s Genzyme takeover bid focuses on Campath
January 10, 2011Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, biotech acquisition
Sanofi-Aventis and Genzyme have come back to the negotiation table to discuss the potential of Genzyme’s multiple sclerosis drug Campath. …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
